Content from Sheryll Mangahas
Sheryll Mangahas is a Data Operations Associate at Moody’s. As part of the Modeling team, she manages company and bioscience analyses.
2B or Not 2B? That Was the Question for Aspartame
In March 2015, the World Health Organization's International Agency for Research on Cancer (IARC) designated glyphosate, the active ingredient in Roundup, as "probably carcinogenic to humans" (Group ...
3M Belgian Settlement Signals Increased Risk of ‘Toxic Torts’ in Europe
"Toxic torts," which are lawsuits alleging damage to human health or the environment caused by specific substances, are increasingly common in the United States. They can cost defendants hundreds of ...
Emerging Damage: The Case of Melamine
Emerging risks evolve through three phases: emerging interest, emerging damage and emerging litigation. During the "emerging interest" phase, scientists, regulators or legal scholars first flag the ...
Fifth-Generation Wireless Technologies: Suspicion vs. Evidence
One of the more surprising recent conspiracy theories to make the rounds of the Internet and social media is that the COVID-19 pandemic is actually a hoax perpetrated by corporations to cover up the ...